Amylyx Pharmaceuticals (AMLX) Change in Cash (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) posted quarterly Change in Cash of $2.5 million for Q1 2026, up 114.11% year-over-year from $1.2 million in Q1 2025, and up 68.54% quarter-over-quarter from $1.5 million in Q4 2025.
Amylyx Pharmaceuticals (AMLX) Change in Cash (2021 - 2026) Analysis & Trends
Amylyx Pharmaceuticals' Change in Cash history runs 6 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- In Q1 2026, Change in Cash rose 114.11% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $168.9 million (up 253.47% YoY), while the FY2025 annual figure was $148.8 million, up 261.59% from the prior year.
- Change in Cash for Q1 2026 stood at $2.5 million, up from $1.5 million in the prior quarter.
- The five-year high for Change in Cash was $166.6 million in Q3 2025, with the low at -$112.5 million in Q3 2023.
- The 5-year median for Change in Cash is $1.5 million (2025), against an average of $10.6 million.
- Peak annual rise in Change in Cash reached 6934.5% in 2025, while the deepest fall reached 5121.08% in 2025.
- Amylyx Pharmaceuticals' Change in Cash stood at -$45.2 million in 2022, then soared by 177.29% to $34.9 million in 2023, then plunged by 84.1% to $5.6 million in 2024, then tumbled by 73.46% to $1.5 million in 2025, then jumped by 68.54% to $2.5 million in 2026.
- Business Quant data shows AMLX's Change in Cash at $2.5 million in Q1 2026, $1.5 million in Q4 2025, and $166.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Amylyx Pharmaceuticals | 4.34 Bn | 4.34 Bn | - | -179.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -179.81 Mn |
| Mar 31, 2026 | 2.49 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 166.63 Mn |
| Jun 30, 2025 | -1.68 Mn |
| Mar 31, 2025 | -17.62 Mn |
| Dec 31, 2024 | 5.56 Mn |
| Sep 30, 2024 | -2.44 Mn |
| Jun 30, 2024 | -95.55 Mn |
| Mar 31, 2024 | 351,000.00 |
| Dec 31, 2023 | 34.94 Mn |
| Sep 30, 2023 | -112.50 Mn |
| Jun 30, 2023 | 133.20 Mn |
| Mar 31, 2023 | 52.04 Mn |
| Dec 31, 2022 | -45.21 Mn |
| Sep 30, 2022 | 40.59 Mn |
| Jun 30, 2022 | -42.96 Mn |
| Mar 31, 2022 | 60.44 Mn |
| Dec 31, 2021 | -26.49 Mn |
| Sep 30, 2021 | 61.58 Mn |